. 2021 Jul 19;64(15):11496–11526. doi: 10.1021/acs.jmedchem.1c00806

Table 2. Inhibition of Human Isolated 5-LOX and 5-LOX Product Formation in Activated PMNL by Amplexichromanol-Derived Compounds (26–48)^e.

graphic file with name jm1c00806_0017.jpg

graphic file with name jm1c00806_0018.jpg

IC₅₀ values (μM).

Residual activities (% control) at 1 μM compound concentration.

Residual activities (% control) at 3 μM compound concentration.

Highlighted data (gray) are from Pein et al.⁶ n.d., not determined.

All values are given as mean ± SEM of single determinations obtained in 3–4 independent experiments.

Table 2. Inhibition of Human Isolated 5-LOX and 5-LOX Product Formation in Activated PMNL by Amplexichromanol-Derived Compounds (26–48)e.